Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study
暂无分享,去创建一个
H. Genant | D. M. van der Heijde | T. Yoneda | H. Yamanaka | Yoshiya Tanaka | T. Takeuchi | N. Ishiguro | N. Okubo | Takeshi Ohira